Wiesbaden, Germany

Franz Lehrach

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz Lehrach. Retrieved from https://idiyas.com/inventor/franz-lehrach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Lehrach: Innovator in Pharmaceutical Compositions

Introduction

Franz Lehrach is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for oral administration.

Latest Patents

Lehrach holds a patent for a pharmaceutical composition that includes at least one xanthine derivative. This composition is designed for oral administration in dosage unit form. His innovative approach has the potential to enhance the effectiveness of pharmaceutical treatments.

Career Highlights

Franz Lehrach has had a distinguished career, working with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on advancing medical science through innovative drug formulations.

Collaborations

Lehrach has collaborated with notable colleagues, including Roland Muller and Klaus Gleixner. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical research.

Conclusion

Franz Lehrach's contributions to pharmaceutical compositions demonstrate his commitment to innovation in medicine. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…